Form 8-K - Current report:
SEC Accession No. 0000898430-01-502411
Filing Date
2001-09-17
Accepted
2001-09-17 00:00:00
Documents
11
Period of Report
2001-08-31
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K d8k.txt 8-K 39195
3 ASSET PURCHASE AGREEMENT DATED 8/31/2001 dex27.txt EX-2.7 180254
4 DISTRIBUTION & LINCENSE AGREEMENT dex1089.txt EX-10.89 65118
5 SUBLICENSE AGREEMENT OF THE FIRST BD dex1090.txt EX-10.90 42325
6 SUBLICENSE AGREEMENT OF THE SECOND BD dex1091.txt EX-10.91 39712
7 SUBLICENSE AGREEMENT OF THE DORKEN dex1092.txt EX-10.92 39774
8 SUBLICENSE AGREEMENT OF THE PUBLIC HEALTH SERVICE dex1093.txt EX-10.93 38804
9 SUBLICENSE AGREEMENT OF THE DIACLONE MONOCLONAL dex1094.txt EX-10.94 36598
10 EMPLOYEE LEASE AGREEMENT DATED 8/31/2001 dex1095.txt EX-10.95 21224
11 SUPPLY AGREEMENT DATED 8/31/2001 dex1096.txt EX-10.96 65197
12 PRESS RELEASE OF THE REGISTRANT DATED 9/5/2001 dex991.txt EX-99.1 5112
  Complete submission text file 0000898430-01-502411.txt   575920
Mailing Address 9 PARKER IRVINE CA 92618
Business Address 9 PARKER IRVINE CA 92618 9494709011
NEXELL THERAPEUTICS INC (Filer) CIK: 0000864009 (see all company filings)

EIN.: 061192468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19153 | Film No.: 1738782
SIC: 2834 Pharmaceutical Preparations